Human IGG B12 anti- primary HIV-1 isolates (PDB: 1HZH)
Welcome To The Antibody Society Webpage
The Antibody Society was formed in 2007 to further the broad interests of antibody engineering and antibody therapeutics, as well as to safeguard the public interest by increasing discussion and activities to create the safe, thorough testing of antibody therapeutics. The Society encompasses this increasingly diverse field, by supporting the superstructure for the engineering of recombinant antibodies, single scaffold binders, etc. through basic and applied research by those in academics and the private sector. The Society also seeks to provide a forum and voice for the thousands of people now working on all facets of this global field. Read our Mission Statement.
The Antibody Society membership.The Antibody Society website is the vehicle for registration of new members, which is now possible via a secure online server,register here !
News and views
IBC's – Antibody Engineering & Therapeutics – Now in its 25th year, Antibody Engineering & Therapeutics has earned its reputation by consistently offering the most current academic research findings and most recent industry updates. Meeting Info Soon To Follow !
Meeting Report 2013 San Diego, now available – A Meeting Report of the 2013 meeting in Huntington Beach has been published in MABS and can be found here !
Updated Antibody Modeling Assessments (AMAs) -
In AMA-I, nine unpublished high-resolution x-ray Fab crystal structures covering a wide range of antigen-binding site conformations were used as benchmark to compare Fv models generated by four structure prediction methodologies. For AMA-II, a more diverse and larger set (eleven unpublished structures) were used as benchmark to compare seven structure prediction methodologies. This webserver compiles information of the assessments, including the benchmark structures, models generated by the participants and highlights of AMA's, together with resources and literature on Antibody modeling. Find detail here!
Listing of approved monoclonal antibodies ! A list has been composed of all therapeutic monoclonal antibodies approved or in review in the European Union or United States.Find the table here !
GIATE: new developments !
GIATE: Guidelines for Information About Therapy Research Experiments.
Fulfilling a need in data management:
•Use to organise your data and track workflow
•Share data within your group and with collaborators
•Enjoy improved ability to plan, retrieve, analyse and report research
Submissions are due as soon as possible, but no later than the end of JUNE. Please identify these submissions to PEDS as being for the Antibody Special Issue (PEDS-ASI) and they will receive an expedited review.
Use your personal or institutional subscriptions for access to PEDS. After one
year all papers published in PEDS are Open Access.
Broad coverage of all topics relevant
to antibody research and development
mAbs is the therapeutics journal of The Antibody Society !